A detailed history of Cubist Systematic Strategies, LLC transactions in Hutchmed (China) LTD stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 12,430 shares of HCM stock, worth $223,740. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,430
Previous 12,430 -0.0%
Holding current value
$223,740
Previous $212,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.36 - $21.78 $203,354 - $270,725
12,430 New
12,430 $212,000
Q4 2023

Feb 14, 2024

BUY
$16.25 - $20.23 $364,585 - $453,880
22,436 New
22,436 $406,000
Q2 2023

Aug 14, 2023

SELL
$10.78 - $17.73 $271,806 - $447,044
-25,214 Reduced 98.47%
393 $4,000
Q1 2023

May 15, 2023

SELL
$13.02 - $19.87 $118,416 - $180,717
-9,095 Reduced 26.21%
25,607 $333,000
Q4 2022

Feb 14, 2023

BUY
$7.65 - $15.51 $136,904 - $277,566
17,896 Added 106.49%
34,702 $512,000
Q3 2022

Nov 14, 2022

SELL
$8.63 - $15.52 $47,180 - $84,847
-5,467 Reduced 24.55%
16,806 $149,000
Q3 2022

Nov 14, 2022

SELL
$8.63 - $15.52 $47,180 - $84,847
-5,467 Reduced 24.55%
16,806 $149,000
Q2 2022

Aug 15, 2022

BUY
$8.59 - $20.77 $8,160 - $19,731
950 Added 4.46%
22,273 $282,000
Q1 2022

May 16, 2022

BUY
$15.52 - $35.65 $330,932 - $760,164
21,323 New
21,323 $403,000
Q4 2020

Feb 16, 2021

SELL
$27.51 - $34.36 $606,182 - $757,122
-22,035 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$25.8 - $34.61 $568,503 - $762,631
22,035 New
22,035 $712,000
Q3 2019

Nov 14, 2019

SELL
$17.84 - $22.69 $32,450 - $41,273
-1,819 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$22.0 - $31.78 $40,018 - $57,807
1,819 New
1,819 $40,000
Q1 2019

May 15, 2019

SELL
$21.27 - $30.58 $200,150 - $287,757
-9,410 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$23.09 - $37.69 $217,276 - $354,662
9,410 New
9,410 $217,000

Others Institutions Holding HCM

About HUTCHMED (China) Ltd


  • Ticker HCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 172,955,008
  • Market Cap $3.11B
  • Description
  • HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...
More about HCM
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.